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ABSTRACT 
 
The most frequent form of hereditary blindness, Autosomal Dominant Optic Atrophy 
(ADOA) is caused by the mutation of the mitochondrial protein Opa1 and the ensuing 
degeneration of retinal ganglion cells. Previously we found that knockdown of OPA1 
enhanced mitochondrial Ca
2+
 uptake (Fülöp et al.,PLoS One 2011). Therefore we studied 
mitochondrial Ca
2+
 metabolism in fibroblasts obtained from members of an ADOA family. 
Gene sequencing revealed heterozygosity for a splice site mutation (c. 984+1G>A) in 
intron 9 of the OPA1 gene. ADOA cells showed a higher rate of apoptosis than control 
cells and their mitochondria displayed increased fragmentation when forced to oxidative 
metabolism. The ophthalmological parameters critical fusion frequency and ganglion cell 
– inner plexiform layer thickness were inversely correlated to the evoked mitochondrial 
Ca
2+
 signals. The present data indicate that enhanced mitochondrial Ca
2+
 uptake is a 
pathogenetic factor in the progress of ADOA. 
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1. Introduction 
 
The most frequent form of hereditary blindness is autosomal dominant optic atrophy 
(ADOA, OMIM165500). The disorder is due to cell death confined to retinal ganglion 
cells which results in bilateral central visual loss, impaired color vision and central visual 
field defects [1,2]. The prevalence of ADOA is estimated to be between 1/50,000 and 
1/10,000 [3,4]. The most frequent cause of type 1 ADOA is the mutation of the OPA1 
gene [5-7]. Opa1 is a dynamin-related GTPase protein and due to alternative splicing its 
gene is transcribed into 8 mRNA isoforms in human [7] encoding proteins of 924-1014 
amino acids. The protein is tethered to the IMM [8-10] and localized in the IMS [8,9]. 
In Western blot analysis 5 separate bands (designated a to e) ranging from 94 to 86 kDa, 
can be detected. Two long isoforms are anchored to the IMM and three soluble short 
forms are located in the IMS. The soluble forms are the proteolytic products of the long 
isoforms [11,12]. (For further details see recently publised excellent reviews [13,14].)  
The fundamental pathology in ADOA is the degeneration of the small (parvo) retinal 
ganglion cells with subsequent atrophy of the optic nerve [13,15,16]. Nevertheless, the 
protein is expressed in all examined human tissues, explaining the accidental development 
of the so-called 'ADOA +' forms characterized by the association of the blindness with 
various neuromuscular disorders [17-19] or hearing loss [20,21]. The vulnerability of 
retinal ganglion cells and that of spiral ganglion cells in the inner ear [22] has been 
attributed to the impairment of ATP production as observed in fibroblasts [23,24] or 
skeletal muscle [25]. Since retinal ganglion cells are unique among neurons in that the 
are exposed to direct sunlight, the ensuing oxidative stress may potentiate the 
consequences of Opa1 dysfunction, leading to apoptosis of these cells [13]. In OPA1
+/-
 
mice the level of postsynaptic density protein 95 and the density of glutamatergic synaptic 
sites were reduced even without loss of mitochondrial membrane potential [26]. This 
observation indicates the significance of Opa1 in maintaining the synaptic architecture and 
connectivity of retinal ganglion cells. 
Knockdown of OPA1 in two human cell lines, in HeLa and H295R (adrenocortical) 
cells, induces enhanced mitochondrial Ca
2+
 uptake [27] and also mitochondrial Ca
2+
 - 
dependent hypersecretion of aldosterone (in H295R cells) [28]. On the other hand, 
excessive accumulation of Ca
2+
 by mitochondria leads to cell death [29-31]. In view of 
these observations it was reasonable to examine mitochondrial Ca
2+
 uptake in ADOA 
patients. Our present data showed a correlation between the Ca
2+
 sequestring ability of 
mitochondria and the grade of impairment of visual parameters.  
 
2. Materials and Methods 
 
2.1 Materials  
 
Bradykinin and digitonin were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Silencing RNA products, Rhod-2 AM, Fluo-4 AM, Mito Tracker Deep Red (MTDR), 
tetramethylrhodamine ethyl ester (TMRE) and 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-
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imidacarbocyanine iodide (JC-1) were purchased from Life Technologies (Paisley, UK). 
Annexin V-FITC was from BD Biosciences, glucose-free medium (E15-079) was from 
GE Healthcare (Piscataway, NJ). D-galactose was purchased from Reanal (Budapest, 
Hungary). Fetal bovine serum (FBS) was obtained from Lonza (Basel, Switzerland). 
Antibodies were used as follows: anti-OPA1 mouse monoclonal antibody (612606, BD 
Biosciences), anti-protein disulphide isomerase mouse monoclonal antibody (ab2792, 
Abcam, Cambridge, UK), anti-mouse immunoglobulin-HRP (NA 931V, GE Healthcare). 
 
2.2 Clinical studies 
 
Seven members of a family with genetically verified ADOA were subjected to detailed 
ophthalmological and neurological examinations including the tests for far and near visual 
acuity (spec. No. 2305 and 2307) (logarithmic visual acuity chart, from Precision Vision, 
Artesia LA), measurement of thickness of retinal nerve fibre layer, ganglion cell and inner 
plexiform layer (optical coherence tomography, Cirrhus HD-OCT, Carl Zeiss Meditec, 
Dublin LA) and critical flicker fusion frequency (CFF). Written informed consent was 
obtained from all patients and controls. As control, two healthy volunteers were also 
examined. After obtaining appropriate consent skin samples used for fibroblast culturing 
were excised from all five adult subjects. The reserach was approved by Hungarian 
Research Ethical Committee and carried out according to the Helsinki declaration. 
 
2.3 Gene sequencing 
 
Sequencing of the coding region and the exon-intron junctions of the OPA1 gene (NM 
015560.2) in patient I/3 was performed by Dr. Josseline Kaplan at the Service Medicale, 
GH Necker Enf. Malades, F-75743 Paris Cedex 15, France. Subsequently the segregation 
analysis of the mutation in the affected family members was performed in our laboratory 
using ABI Prism 3500 DNA Sequencer (Applied Biosystems, Foster City, CA). Genetic 
sequence was compared with the human reference genome (NM_001005360, 
ENSG00000079805) using NCBI’s Blast® application. 
 
 
2.4 Cell culture and transfection 
 
Fibroblasts acquired from human skin biopsies were grown in DMEM containing 20% 
heat inactivated FBS, 100 U/ml penicillin and 100 µg/ml streptomycin. Passage numbers 3 
-7 were used. 
 
2.5 Apoptosis 
 
Control cells or cells exposed to 0.1 mM H2O2 for 4 hours at 37
o
C were dyed with 
FITC labeled annexin V (1:100) in a binding buffer (10 mM HEPES pH 7.4, 140 mM 
NaCl, 2.5 mM CaCl2) for 15 minutes. The cells were examined with confocal microscopy. 
 
2.6 Experimental conditions 
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The cells were superfused at room temperature with a modified Krebs-Ringer solution 
containing 140 mM Na
+
, 4.5 mM K
+
, 1.2 mM Ca
2+
, 0.5 mM Mg
2+
, 5 mM Hepes and 2 
mM HCO3

 (pH 7.4). Flow rate was ~1ml/min. Permeabilization with 25 µM digitonin 
(for 8 min) was carried out in a cytosol-like medium (117 mM KCl, 6 mM NaCl, 1 mM 
KH2PO4, 2 mM Na
+
 pyruvate, 2 mM Na
+
 succinate, 2 mM K
+
 ADP, 2 mM EGTA, 0.5 
mM Mg
2+
 and 10 mM K
+
 HEPES). The medium containing 5 µM free Ca2+ was composed 
with the Chelator software [32]. 
 
2.7 Confocal microscopy  
 
Cytoplasmic and mitochondrial Ca
2+
 uptake (monitored with Fluo-4 and Rhod-2, resp.), 
mitochondrial membrane potential (TMRE or JC-1) and mitochondrial morphology (MTDR) 
were examined with confocal microscopy (LSM 510) as described [27]. Apoptosis was 
studied applying annexin V-FITC with a Zeiss LSM 710 confocal laser scanning 
microscope, equipped with a 63x/1.4 oil immersion objective (Plan-Apochromat, Zeiss) 
and operated with ZEN 9.0 software.  
 
2.8 Electrophoresis and immunoblotting 
 
SDS electrophoresis and immunoblotting were performed as described [27]. Anti-
Opa1 and anti-PDI primary antibodies and anti-mouse secondary antibody were applied at 
a dilution of 1:500, 1:3000 and 1:5000, respectively. Protein content of the samples was 
measured with BCA assay. 
 
2.9 Statistics 
 
Means + S.E.M. are shown. For estimating significance of differences Kruskal-Wallis 
test (followed by Dunnett’s test) was used. Correlation was calculated with Pearson’s or 
Spearman’s test. Data were analyzed with Statistica 11.  
 
3. Results 
 
3.1 Clinical examinations and genetic analysis 
 
Seven members of a family with hereditary visual impairment were subjected to 
detailed ophthalmological and neurological examination (Fig 1a, Table 1 and Suppl. 
Tables 1 – 5). The most severe progress of ADOA has been diagnosed in patient I/1. 
Patient I/1 and I/2 beside the visual impairment, had mild neurological symptoms. The 
four children did not have any neurological symptoms. We had no contact with the mother 
of the three adult siblings but based on the hetero-anamnestic data, she had serious visual 
impairment. The diagnosis has been confirmed in all the seven patients by genetic 
investigations which revealed a new heterozygous splice site mutation (c. 984+1G>A) in 
the OPA1 gene. Western blot analysis of fibroblasts from patient I/1 detected reduced 
expression of Opa1 (as related to protein disulphide isomerase), however, there was no 
change in the pattern of OPA1 isoforms (Fig. 1b). The results of the Western blot are 
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compatible with the ability of the antibody to recognize amino acids 708-830, a site 
downstream of the splice site mutation.  
For studying mitochondrial state and function, fibroblasts were cultured from the three 
adult patients (I/1, I/2 and I/3) who also showed mild neurological symptoms (Suppl. 
Tables 3-5) and two healthy controls (Ctrl2 and Ctrl2). In these five subjects strong 
correlation was found between the functional parameter CFF and the thickness of retinal 
gangion cell - inner plexiform layer (R
2 
= 0.961, p = 0.0197) (Suppl. Fig. 1). 
 
3.2 Morphology of mitochondria 
 
Morphology of mitochondria in fibroblasts of the most severely diseased patient I/1 
(Table 1) was examined with MTDR staining. No difference could be observed between 
control and ADOA samples under control conditions. When oxidative (mitochondrial) 
metabolism was forced by culturing the cells in galactose containing medium for 72 hours 
[23] significant mitochondrial fragmentation took place in the mutant cells whereas the 
effect was negligible in the controls (Suppl. Figs 2 - 4). 
 
3.3 Mitochondrial Ca
2+
 uptake 
 
In order to elucidate whether mutant fibroblast cells have enhanced mitochondrial Ca
2+
 
uptake as observed in Opa1 silenced human cell lines [27] we monitored cytosolic and 
mitochondrial [Ca
2+
] with Fluo-4 and Rhod-2, respectively. Stimulation with 1 nM 
bradykinin evoked a rapid cytosolic Ca
2+
 signal that was ensued by a more prolonged 
increase in mitochondrial [Ca
2+
] (Figs 2a, c and d). Since mitochondrial Ca
2+
 uptake 
depends on the amplitude of cytosolic Ca
2+
 signal, the mitochondrial responses were also 
related to the cytosolic responses (Fig. 2e). The peak of mitochondrial Ca
2+
 signal 
exceeded that of the pooled controls only in the cells of patient I/1 (p = 0.015) who, out of 
the 3 siblings, displayed the greatest progress of ADOA. Mitochondrial membrane 
potential in her fibroblasts, measured with TMRE and JC-1, was comparable with that of 
controls (not shown), therefore no change in the driving force could account for the 
enhanced mitochondrial Ca
2+
 uptake.  
To rule out any cytosolic factor modifying mitochondrial Ca
2+
 metabolism, the 
transport was examined also in permeabilized cells. Replacing the Ca
2+
 free cytosol-like 
superfusion medium with one containing 5 M Ca2+ induced a rapid increase in 
mitochondrial [Ca
2+
] (Fig. 2b). Both the slope and the peak of mitochondrial Ca
2+
 signal in 
the fibroblasts of patient I/1 exceeded those of controls (p = 0.007 and 0.015, resp., Fig. 
2f), ruling out the role of cytosolic factors in the enhancement of mitochondrial Ca
2+
 
sequestring ability. 
 
3.4 Apoptosis 
 
Deficient Opa1 function enhances apoptotic processes both under control conditions 
and after exposure to apoptotic stimuli. It may have diagnostic significance that 
progression of ADOA is indicated by increased apoptosis rate [13]. Therefore we 
examined the apoptotic state of the cultured fibroblasts with FITC-labelled annexin V. 
This fluorescent ligand attaches to the cell membrane already in an early stage of the 
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apoptosis. Under resting conditions the apoptotic rate was already higher in the ADOA 
patients (15 % vs. 2.5 % in average, Fig. 3c). Four hours after exposing the fibroblasts to 
the apoptotic reagent H2O2 (0.1 mM) the apoptotic rate in the ADOA cells (27 % in 
average) far exceeded that in the controls (5.3 %) (Fig. 3d and Suppl. Fig. 5). These 
observations show increased sensitivity of ADOA cells to apoptotic stimuli.  
 
3.5 Clinical data in function of mitochondrial Ca
2+
  
 
The purpose of the present study was to elucidate the role of mitochondrial Ca
2+
 in the 
development of visual impairment in ADOA patients. Therefore we analyzed the 
correlation between the peak of bradykinin-induced mitochondrial Ca
2+
 uptake and the 
clinical parameters in all five examined subjects. A significant correlation was found 
between [Ca
2+
]m and CFF (p=0.0232, Fig. 3a) as well as [Ca
2+
]m and the thickness of 
ganglion cell layer (p=0.0283, Fig. 3b) of these patients. Very high apoptosis rate was 
observed in resting (Fig. 3c) and H2O2 - stimulated cells ( Fig. 3d) of patient I/1 who 
showed the highest Ca
2+
 response to bradykinin. At the same time, the fibroblasts of 
patient I/3 displayed moderate ophthalmological alterations despite displaying control-like 
mitochondrial Ca
2+
 parameters. This latter observation indicates that retinal damage may 
begin before any detectable change in cellular Ca
2+
 metabolism occurs.  
 
4. Discussion 
 
Opa1 regulates mitochondrial morphology [33]. Knockdown of the OPA1 gene 
brings about the fragmentation of mitochondria [10,34,35] and drastic desorganisation 
of the cristae [34,36-39]. Also, Opa1 defect often leads to apoptosis [34,40].  
 The majority of cytochrome c reductase and F1F0 ATPase [41], that of cytochrome c 
oxidase [42] as well as the uncoupling protein 1 (in brown adipocytes) [43] are found 
within the crista membrane. Only 10-15 % of cytochrome c is found free in the 
intermembrane space while the major fraction can be found in the cristae [44,45]. The 
release of cytochrome c from digitonin-permeabilized mitochondria is significantly 
enhanced after exposure to t-Bid that evokes the disassembly of Opa1 oligomers [40,46] 
and a drastic increase in the junction diameter (i.e. the transition between the so-called 
inner boundary membrane and crista membrane) [45]. These data indicate that diffusion 
through the junction is controlled by Opa1. Dilatation of the junction may facilitate the 
diffusion between the intermembrane space and the lumen of cristae and thus may modify 
mitochondrial metabolism [13,47]. 
In the fibroblasts of ADOA patients mutations in the GTPase domain or deletion of the 
GTPase effector domain increased the susceptibility to apoptosis, irrespective of whether 
mitochondria were fragmented or not [48]. Cell death may be a consequence of excessive 
Ca
2+
 loading of mitochondria [29-31]. Yet, we are not aware of studies on mitochondrial 
Ca
2+
 metabolism in ADOA patients. Therefore we studied mitochondrial Ca
2+
 uptake in 
ADOA patients, using their cultured fibroblasts under well-controlled laboratory 
conditons. 
Ca
2+
 uptake from the mitochondrial intermembrane space into the mitochondrial 
matrix occurs predominantly through the MCU complex containing the Ca
2+
 selective ion 
channel MCU (Mitochondrial Calcium Uniporter) [49,50] and several accessory 
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proteins [51-54]. Recalling that OPA1 knockdown increases the diffusibility of 
cytochrome c through the crista junctions [38,45,46] we postulated that if significant 
Ca
2+
 uptake into the matrix occurs from the lumen of the cristae, reduced expression of 
Opa1 would increase the access of Ca
2+
 to the transporters in the crista membrane and 
consequently would enhance Ca
2+
 uptake. Experimental results have supported this 
postulation. In HeLa and H295R adrenocortical cells agonist-induced cytosolic 
Ca
2+ 
signals were transferred into the mitochondria. The rate and amplitude of the 
secondary mitochondrial [Ca
2+
] rise were increased after knockdown of OPA1, as 
compared with cells transfected with control RNA or mitofusin1 siRNA. (Mfn1 siRNA 
was applied as control for OPA1 siRNA since they induced comparable fragmentation of 
the mitochondrial network.) In permeabilized cells the rate of Ca
2+ 
uptake by depolarized 
mitochondria was also increased in OPA1-silenced cells. The enhancement of Ca
2+
 
transport seemed to be independent of Mitochondrial Permeability Transition Pore, since it 
was not influenced by its inhibitor cyclosporin A [27]. The biological significance of the 
enhanced Ca
2+
 uptake in OPA1-silenced H295R cells was indicated by enhanced 
aldosterone production [28]. Although our data in HeLa cells were partly at variance with 
those of Kushnareva et al. [55] (in this respect see [56]), studies on the Ca
2+
 retention 
capacity of mitochondria in OPA1-silenced murine retinal ganglion cells [16] and the 
Ca
2+
 sensitivity of mitochondrial permeability transition pore in OPA1-silenced HeLa cells 
[55] are in harmony with our observations. The report that knock-down of Opa1 
increased the amplitude of Ca
2+
 uptake and the Ca
2+
 retention capacity in murine cardiac 
mitochondria [57] also supports the conclusion that an impairment of OPA1 function 
may lead to enhanced mitochondrial Ca
2+
 signalling. 
The alteration of Ca
2+
 metabolism in OPA1-silenced cells led to the idea that enhanced 
mitochondrial Ca
2+
 uptake in ADOA patients may be a factor participating in the 
pathogenesis of blindness. In this respect it has no significance whether the increase of 
mitochondrial Ca
2+
 uptake was induced solely by enhanced diffusion of Ca
2+
 to MCU 
within the cristae or also alteration in the expression profile or location of mitochondrial 
Ca
2+
 handling proteins. In the family investigated in this study three generations of 
patients showed the dominant nature of their visual impairment. Sequence analysis of 
OPA1 gene detected a previously non-described mutation (c. 984+1G>A) in intron 9. The 
Western blot analysis of the fibroblasts revealed reduced expression of Opa1 protein but 
no detectable change in the isoform pattern. In fact, no change in the ratio of long and 
short isoforms are expected in case of mutation at the splice site of the 9th intron since 
alternate splicings (yielding short isoforms) are evoked by cleavage in exons 4, 4b or 5b 
[13,58]. The applied antibody recognizes amino acids 708-830 therefore it may not 
recognize any mutant protein. 
Based on the severity of their complains, their visual acuity, thickness of the retinal 
ganglion cell layer and CFF patient I/1 showed the most progressed stage of ADOA. All 
the examined adult patients exhibited slight neurological symptoms as well, therefore the 
disease of this family may be regarded as "ADOA +". Their mitochondrial morphology 
was comparable to that of the two control subjects when the fibroblasts were cultured 
under conventional conditions., However, when fibroblasts were forced to rely on 
oxidative (mitochondria – dependent) metabolism by the application of a galactose-
containing medium [23] striking mitochondrial fragmentation took place. This 
observation revealed the incipient impairment of mitochondrial function.  
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The present study revealed a significant negative correlation between mitochondrial 
Ca
2+
 uptake and two clinically important ophthalmological parameters, namely CFF and 
the thickness of the retinal ganglion cell – inner plexiform layer. Now the question may 
arise what the causal relation between Ca
2+
 uptake and retinal damage is. The bulk of 
evidence shows that excessive Ca
2+
 uptake may lead to cell death. On the other hand, 
moderate impairment of several ophthalmological parameters could already be measured 
in patient I/3, although her Ca
2+
 parameters were comparable with those of the controls. 
As far as conclusion may be drawn at the low number of observations the present data 
suggest that retinal damage may begin without a detectable change in mitochondrial Ca
2+
 
uptake whereas further enhancement of Ca
2+
 uptake contributes to the progress of the 
disease. However, if mitochondrial turnover rate is higher in the retinal ganglion cells than 
in fibroblasts depletion of the normal Opa1 pool might occur earlier in the ganglion cells 
than in fibroblasts and in such a case a causative role of Ca
2+
 in triggering ADOA cannot 
be ruled out. 
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Legend of Figures     
 
Fig. 1. Mutation OPA1 gene and reduced expression of intact Opa1 protein. (A) 
Genealogical tree of the examined ADOA family. The filled-in symbols represent carriers 
of a splice site mutation (c. 984+1G>A) in intron 9 of the OPA1 gene. The arrow shows 
the proband (the first affected family member who sought medical attention for her genetic 
disorder). (B) Western blot revealed reduced protein expression but maintained ratio of L 
(long) and S (short) isoforms in patient I/1 as compared to the control person Ctrl1. (NB 
The applied anti-Opa1 antibody does not recognize the mutated protein.) Protein 
disulphide isomerase (PDI) was used as loading control. 
 
Fig. 2. Mitochondrial Ca
2+
 uptake. (A) Bradykinin (1 nM) - induced Ca
2+
 signal as 
monitored with laser scanning confocal microscopy in an intact control cell. The cell was 
preloaded with Fluo-4 and Rhod-2 for monitoring changes of cytosolic and mitochondrial 
[Ca
2+
], respectively. Stimulation is indicated by horizontal line. (B) Mitochondrial Ca
2+
 
signal (Ca
2+
m) in a permeabilized, Rhod-2 preloaded cell. Ca
2+
 uptake was induced by 
replacing the Ca
2+
 -free cytosol-like superfusion medium with one containing 5 M Ca2+, 
as indicated by horizontal line. (C) The peak of bradykinin - induced cytosolic Ca
2+
 signal, 
related to Fluo-4 fluorescence in the control period, is shown. (D) The peak of bradykinin 
- induced mitochondrial Ca
2+
 signal, related to Rhod-2 fluorescence in the control period, 
is shown. (E) The peak of bradykinin - induced mitochondrial Ca
2+
 signal related to the 
corresponding cytosolic Ca
2+
 peak (Ca
2+
m/Ca
2+
c) is shown. (F) The initial rate of 
mitochondrial Ca
2+
 uptake (Ca2+m/t, blue) and maximal mitochondrial Ca
2+
 uptake 
(yellow) in permeabilized cells after raising the [Ca
2+
] of the Ca
2+
 -free cytosol-like 
superfusion medium with one containing 5 M Ca2+. In panels C-E the number of cells is 
shown in the bottom of the respective columns. 
 
Fig. 3. Correlation between the ratio of mitochondrial to cytosolic Ca
2+
 signals (mean + 
S.E.M., see Fig. 2E) and (A) Critical Fusion Frequency (CFF, see Table 1), (B) thickness 
of ganglion cell and inner plexifrom layer (see Table 1) and (C) percentage of apoptotic 
fibroblasts incubated without or (D) after 4 hr exposure to 0.1 mM H2O2 . Control data are 
shown in white, ADOA data are shown in red. The number of examined cells was between 
60 and 300 per subject. 
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Table 1  Ophthalmological data of the examined subjects 
 
name gender age 
(year) 
visual 
acuity (far, 
right) 
mean RNFL 
thickness 
(right) 
 
mean ganglion 
cell + IPL 
thickness   (right) 
CFF 
(Hz), 
right 
 
CFF 
(Hz), 
left 
 
I/1 F 38 0.16 59 (1) 42 (1) 32 32 
I/2 M 43 0.1 59 (1) 49 (1) 34 34 
I/3 F 36 0.16 61 (1) 55 (1) 36 36 
II/1 M 11 0.25     
II/2 M 6 0.1     
II/3 F 6 0.5     
II/4 F 8 0.32   38 38 
        
Ctrl1 M 28 1.6 88 (22) 86 (59) 40 40 
Ctrl2 M 35 1.25 98 (65) 80 (26) 40 40 
 
RNFL retinal nerve fiber layer, IPL inner plexiform layer, CFF critical flicker fusion frequency  
Normal range for visual acuity is ≥1;  that for  CFF is ≥40. Thickness is expressed in μm, the values in brackets show  the percentile 
values of age-matched controls.  
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Legend of suppl. Figures 
 
Suppl. Fig.1. Correlation of critical flicker fusion frequency (CFF) and mean thickness of 
retinal gangion cell - inner plexiform layer (IPL) (R
2 
= 0.961, p = 0.0197). The patients' 
data are shown with dark circle, the pooled control data are shown with empty circles.  
 
Suppl. Fig.2. Examples for (A) filamentous, (B) balloon-like and (C) fragmented 
mitochondrial pattern. The optical slice was 1.1 µM. 
 
Suppl. Fig.3. Morphology of mitochondria derived from (A) control Ctrl1 and (B) patient 
I/1, after incubating the fibroblasts for 72 hours in galactose-containing medium. The 
optical slice was 1.1 µM. 
 
Suppl. Fig. 4. Mitochondrial morphology. Morphology of mitochondria as classified by 
Zanna et al. [23], is shown after incubation in control (glucose containing) medium or 
after 4 days incubation in galactose containing medium. Forty cells of control Ctrl1 and 31 
cells of patient I/1 were examined after culturing in control medium whereas 27 and 36 
cells, resp., were studied after incubation in galactose containing medium. For images of 
filamentous, balloon-like and fragmented mitochondria see Suppl. Fig. 1. 
  
Suppl. Fig. 5. Examination of apoptosis in fibroblasts of (A) control Ctrl1 and (B) patient 
I/1 after 4 hr exposure to 0.1 µM H2O2. The cells were dyed with Annexin V – FITC. The 
optical slice was 2.5 µM. 
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Supplementary Table 1  Results of ophthalmological examinations* 
 
 
name 
 
gender 
Visual 
acquity 
far, 
right 
Visual 
acuity 
far, left 
Visual 
acuity 
near, 
right 
Visual 
acuity 
near, 
left 
mean  
ganglion 
cell + IPL 
thickness 
right 
mean 
ganglion 
cell + IPL 
thickness  
left 
CFF 
(Hz), 
right 
 
CFF (Hz), 
left 
 
I/1 F 0.16 0.1 0.25 0.2 42 (1) 42 (1) 32 32 
I/2 M 0.1 0.063 0.16 0.1 49 (1) 50 (1) 34 34 
I/3 F 0.16 0.125 0.08 0.1 55 (1) 52 (1) 36 36 
          
Ctrl1 M 1.6 1.6 1 1 86 (59) 85 (53) 40 40 
Ctrl2 M 1.25 1.25 1 1 80 (26) 77 (15) 40 40 
 
*Thickness is expressed in μm, the values in brackets show  the percentile values of age-matched controls 
RNFL retinal nerve fiber layer, IPL inner plexiform layer, CFF critical flicker fusion frequency  
Normal range for visual acuity is ≥1; that for  CFF is ≥40 
 
Supplementary Table 2  Results of ophthalmological examinations: thickness* of retinal 
nerve fibre layer (RNFL) 
 
Name RNFL 
right  
superior 
RNFL 
right 
nasal 
RNFL 
right 
inferior 
RNFL right 
temporal 
RNFL left 
superior 
RNFL 
left 
nasal 
RNFL 
left 
inferior 
RNFL left 
temporal 
I/1 62 (1) 63 (29) 69 (1) 41 (1) 78 (1) 61 (22) 86 (1) 41 (1) 
I/2 70 (1) 55 (7) 63 (1) 49 (5) 82 (1) 56 (13) 64 (1) 46 (3) 
I/3 71 (1) 54 (9) 69 (1) 48 (7) 69 (1) 56 (11) 68 (1) 35 (1) 
         
Ctrl1 121 (48) 62 (22) 113 (19) 57 (21) 126 (62) 59 (17) 104 (6) 63 (43) 
Ctrl2 116 (41) 70 (49) 138 (82) 67 (63) 108 (22) 57 (13) 108 (15) 81 (90) 
 
*Thickness is expressed in μm, the values in brackets show the percentile values of age-matched controls.
 
Supplementary Table 3  The neurological symptoms of Patients I/1, I/2 and I/3 
 
Patient Hypoacusis Paresis Deep tendon 
reflexes 
Ataxia Peripheral 
sensory 
deficit 
I/1 No No Decreased in 
the upper limbs 
Dysmetria and 
mild limb ataxia 
in the upper limbs 
No 
I/2 Yes No Decreased in all 
4 limbs 
Dysmetria and 
mild limb ataxia 
in the upper limbs 
No 
I/3 No No Normal Mild dysmetria in 
the upper limbs 
No 
 
Supplementary Table 4  VEP component latency in full field stimulation of Patients I/1, 
I/2, I/3 
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Patient 
VEP Studies 
Left Eye (Cz-Oz) Right Eye (Cz-Oz) 
N75 (ms) P100.(ms) N145 (ms) N70 (ms) P100.(ms) N145 (ms) 
I/1 U U U U U U 
I/2  U U U U U U 
I/3  91.5 129.8 165.3 91.8 124.5 160.5 
 
N  and P:  positive (P) or negative (N) wave, the following number indicates the average peak latency 
U: unreproducible 
 
 
Supplementary Table 5  Nerve conduction studies 
 
Patient Left median nerve motor Left peroneal nerve motor Right sural nerve 
 
DL 
(ms)  
Ampl 
(mV)  
CV 
(m/s) 
DL 
(ms) 
Ampl 
(mV)  
CV 
(m/s) 
DL 
(ms) 
Ampl 
(mV)  
CV 
(m/s) 
normal 
value 
Norm≥5 Norm≥5 
Norm≥ 
48 
Norm≥5 Norm≥3 
Norm≥ 
40 
Norm≥5 Norm≥5 
Norm≥ 
40 
I/1 4.0 11.7 57 5.4  1.9 49 2.5 8.1 46 
I/2 4.0 6.2 63 4.9 6.8 48 2.9 12 45 
I/3 3.9 4.2 58 4.8 3.9 47 3.1 8.0 45 
II/1 3.1 3.8 54 4.9 2.2 45 3.0 12 53 
II/2 2.5 4.4 54 4.2 1.9 44 2.5 24 62 
II/3 - - - 3.5 1.2 62 2.1 30 58 
II/4 - - - 3.2 2.7 59 2.6 18 53 
 
Ampl amplitude, CV conduction velocity, DL distal latency 
 
 
